Paper Details

  1. Home
  2. Paper Details

Metformin is a reasonable first-line treatment option for non-obese women with infertility related to anovulatory polycystic ovary syndrome--a meta-analysis of randomised trials.

Author: JohnsonNeil

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Metformin and clomiphene showed no significant difference in effectiveness as ovulation induction agents for non-obese women with anovulatory PCOS. Both are suitable options for first-line treatment.
Paper Details　
Original Abstract of the Article :
BACKGROUND: There are differences in opinion as to whether metformin should play a role in the primary treatment of anovulatory infertility for women with polycystic ovary syndrome (PCOS). AIM: The aim of this study was to ascertain the best available evidence comparing metformin versus clomiphene ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1111/j.1479-828X.2010.01274.x

データ提供：米国国立医学図書館（NLM）

Metformin: A New Hope for Non-Obese Women with PCOS-Related Infertility

This study explores the effectiveness of metformin as a first-line treatment for non-obese women with polycystic ovary syndrome (PCOS)-related infertility. The authors conducted a meta-analysis of randomized controlled trials to compare the efficacy of metformin with clomiphene, a commonly used fertility drug. Their findings suggest that metformin is a viable and potentially equally effective option for non-obese women with PCOS-related infertility.

Navigating the Desert of Infertility: Finding a Path to Parenthood

This study offers hope for women with PCOS-related infertility. The authors' findings suggest that metformin, a medication commonly used for diabetes, may be a viable and effective treatment option for non-obese women struggling to conceive. Imagine the desert of infertility as a vast and challenging landscape. Metformin, in this analogy, is like discovering a hidden oasis, offering a promising path to parenthood.

The Oasis of Fertility: Empowering Women to Achieve Their Dreams

This research provides valuable information for women with PCOS-related infertility. It suggests that metformin may be a safe and effective option for non-obese women seeking to conceive. This finding could empower women to explore new pathways to achieve their dreams of starting a family. It's like discovering a hidden oasis in the desert of infertility, offering a refreshing and empowering solution.

Dr.Camel's Conclusion

This study provides a refreshing perspective on treatment options for non-obese women with PCOS-related infertility. It's like finding a hidden oasis in the desert of infertility, offering a promising path to parenthood. By exploring the potential of metformin, we may be able to provide more effective and personalized treatment options for women seeking to achieve their dreams of having a family.

Date :
  1. Date Completed 2011-07-28
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

21466513

DOI: Digital Object Identifier

10.1111/j.1479-828X.2010.01274.x

Related Literature

Article Analysis
・Effective treatment of polycystic ovary syndrome
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.